Clearly, the wide variability in FMR1 methylation across different FXS hESCs lines runs counter the claim that gene inactivation is initiated by the end of the first trimester and calls for re-evaluation of the timing of FMR1 hypermethylation in FXS (reviewed by [23]). The gene discussed is FMR1; the disease is fragile X syndrome.